2011•Leukemia & lymphoma/Leukemia and lymphomaRequires access

Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature

Reza Setoodeh, Ling Zhang

Open publisher page 5 citations

Abstract

Hairy cell leukemia, a rare B-cell lymphoproliferative neoplasm, accounts for about 2% of all leukemias. Bone marrow and spleen are typical sites of involvement. Patients most commonly present with...

About this research paper

What this paper is about

Hairy cell leukemia, a rare B-cell lymphoproliferative neoplasm, accounts for about 2% of all leukemias. Bone marrow and spleen are typical sites of involvement. Patients most commonly present with...

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Hairy cell leukemia, a rare B-cell lymphoproliferative neoplasm, accounts for about 2% of all leukemias. Bone marrow and spleen are typical sites of involvement. Patients most commonly present with...

Key concepts: Hairy cell leukemia, Cladribine, Pentostatin, Medicine, Pancytopenia, Leukemia, Purine analogue, Hairy Cell

Related papers

Back to paper searchBrowse research topicsOriginal source
Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature — Research Paper | ScholarLens